Dr. Boudoulas earned his medical degree from Ohio State University College of Medicine in 2001. He completed his internal medicine residency at Ohio State’s Medical Center. Dr. Boudoulas completed a postdoctoral research fellowship at Harvard Medical School’s Department of Genetics in Boston, Mass. He also completed a cardiology fellowship at Vanderbilt University in Nashville, Tenn., and an interventional cardiology fellowship at Johns Hopkins University in Baltimore, Md.
Dr. Boudoulas has been the recipient of several research grants, and he has also published a number of original manuscripts. His clinical interests include interventional cardiology, coronary artery disease and acute coronary syndromes. Dr. Boudoulas’s research focuses on cardiovascular genetics and translational research.
Ohio State University College of Medicine
Ohio State University Wexner Medical Center
7/1/2002 - 6/30/2004
Specialties and conditions I treat
- Interventional Cardiology
- Cardiac Catheterization
- Percutaneous Coronary Intervention
- Acute Coronary Syndrome
- Heart Attack
- Cardiovascular Diseases
- Coronary Care Units
- Angioplasty, Balloon, Coronary
- Coronary Angiography
- Heart Valve Diseases
Locations where I practice
More about my work
Vanderbilt University Medical Center
7/1/2005 - 6/30/2008
Johns Hopkins Hospital
7/1/2008 - 6/30/2009
American Board of Internal Medicine
American Board of Internal Medicine (Subspecialty: Cardiovascular)
American Board of Internal Medicine (Subspecialty: Interventional Cardiology)
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 07/24/2016, Dr. Boudoulas has reported no financial relationships with medical device, research and/or drug companies.